# SODIUM HYDROXIDE URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid0029634 Categories: beauty, cleaning, industrial, pharma Functions: Binder, Catalyst, Cleaning agent, Fragrance, Oxidizing agent, Processing aids not otherwise specified, Stabilizing agent, Surfactant (surface active agent), alkalinizing agent, chemical peel, pH balancer, pH regulating agent Identifier: DTXSID0029634 > SODIUM HYDROXIDE is used as binder / catalyst. EPA CPDat observed this chemical in 11688 composition records across product categories including Construction and building materials, Raw materials, Home maintenance. Assessed from 179 sources. ## Safety assessment - Chemical concern: not yet assessed - Rationale: EPA CPDat observed this chemical in 11688 composition records across product categories including Construction and building materials, Raw materials, Home maintenance. ## Regulatory status - US: commercial use observed — EPA CPDat observed this chemical in 11688 composition records across product categories including Construction and building materials, Raw materials, Home maintenance. EPA CPDat classifies this chemical for functional uses including pH regulating agent, pH balancer, alkalinizing agent. - US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 0.8 %w/w - US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SOLUTION/ DROPS; Potency: ADJ PH - US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION/ DROPS; Potency: ADJ PH - US: inactive ingredient database — Route: BUCCAL; Dosage form: FILM; Potency: 0.09 mg - US: inactive ingredient database — Route: BUCCAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 5 mg - US: inactive ingredient database — Route: BUCCAL; Dosage form: MOUTHWASH; Potency: 2 mg/1ml - US: inactive ingredient database — Route: DENTAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: DENTAL; Dosage form: PASTE; Potency: 0.6 %w/w - US: inactive ingredient database — Route: DENTAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: ENDOTRACHEAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: ENDOTRACHEAL; Dosage form: POWDER, FOR SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: ENDOTRACHEAL; Dosage form: SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: EPIDURAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: EPIDURAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: EPIDURAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: EXTRACORPOREAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INFILTRATION; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INFILTRATION; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTERSTITIAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-AMNIOTIC; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-ARTERIAL; Dosage form: INJECTION; Potency: 176 mg - US: inactive ingredient database — Route: INTRA-ARTERIAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-ARTERIAL; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-ARTERIAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-ARTERIAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRA-ARTICULAR; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: ADJ PH - US: inactive ingredient database — Route: INTRABURSAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRACARDIAC; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRACAUDAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRACAUDAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRACAVERNOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRACAVITARY; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRACAVITARY; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRADERMAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRADERMAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRADERMAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: ADJ PH - US: inactive ingredient database — Route: INTRADISCAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRALESIONAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 176 mg - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 7.01 mg - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 0.35 %w/v - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 78 mg - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 27 mg - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: LIQUID; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: 5.4 mg - US: inactive ingredient database — Route: INTRAOCULAR; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAPERITONEAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAPERITONEAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAPLEURAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRASPINAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRASYNOVIAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRASYNOVIAL; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRASYNOVIAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: ADJ PH - US: inactive ingredient database — Route: INTRATHECAL; Dosage form: INJECTION; Potency: 176 mg - US: inactive ingredient database — Route: INTRATHECAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRATHECAL; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRATHECAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRATHECAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRATUMOR; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRATUMOR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVASCULAR; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVASCULAR; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVASCULAR; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTABLE, LIPOSOMAL; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 456 mg - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 136.55 mg - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 78.36 mg - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 78 mg - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SUSPENSION, LIPOSOMAL; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: LIQUID; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: POWDER; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: SOLUTION; Potency: 2.78 %w/v - US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: SOLUTION, CONCENTRATE; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVESICAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVITREAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: INTRAVITREAL; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: IONTOPHORESIS; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: IRRIGATION; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: NASAL; Dosage form: SOLUTION; Potency: 20 mg - US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY; Potency: ADJ PH - US: inactive ingredient database — Route: NASAL; Dosage form: SPRAY, METERED; Potency: ADJ PH - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: DROPS; Potency: NA - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: EMULSION; Potency: 0.02 %w/v - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: GEL; Maximum daily exposure: 6 mg - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.05 %w/v - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: ADJ PH - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: ADJ PH - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Potency: 60 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED; Potency: 0.08 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 0.01 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Potency: 0.25 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Potency: 1.5 mg - US: inactive ingredient database — Route: ORAL; Dosage form: CONCENTRATE; Potency: 10 mg/5ml - US: inactive ingredient database — Route: ORAL; Dosage form: ELIXIR; Potency: ADJ PH - US: inactive ingredient database — Route: ORAL; Dosage form: EMULSION; Potency: ADJ PH - US: inactive ingredient database — Route: ORAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 11 mg - US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: ORAL; Dosage form: LIQUID; Potency: 2 mg/5ml - US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 9 mg - US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 9120 mg - US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Potency: 400 mg - US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Potency: 71 mg/5ml - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 10 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: NA - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 4 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 13 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 8 mg - US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 1 mg - US: inactive ingredient database — Route: PARENTERAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: PARENTERAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: PARENTERAL; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: PARENTERAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: PERIDURAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: PERINEURAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: PERIODONTAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: RECTAL; Dosage form: ENEMA; Potency: 0.44 %v/v - US: inactive ingredient database — Route: RECTAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: RECTAL; Dosage form: SOLUTION; Potency: NA - US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: AEROSOL, METERED; Potency: ADJ PH - US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: POWDER; Potency: ADJ PH - US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: SOLUTION; Potency: 8 %w/v - US: inactive ingredient database — Route: RETROBULBAR; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: SOFT TISSUE; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBARACHNOID; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCONJUNCTIVAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 31.45 mg - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 1 %w/v - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: SUSPENSION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: NA - US: inactive ingredient database — Route: SUBMUCOSAL; Dosage form: INJECTION; Potency: ADJ PH - US: inactive ingredient database — Route: SUBMUCOSAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 69 mg - US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM, AUGMENTED; Maximum daily exposure: 6 mg - US: inactive ingredient database — Route: TOPICAL; Dosage form: DISC; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: EMULSION; Potency: 0.2 %w/w - US: inactive ingredient database — Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 20 mg - US: inactive ingredient database — Route: TOPICAL; Dosage form: JELLY; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: LIQUID; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 21 mg - US: inactive ingredient database — Route: TOPICAL; Dosage form: LOTION, AUGMENTED; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT, AUGMENTED; Potency: 0.11 %w/w - US: inactive ingredient database — Route: TOPICAL; Dosage form: SHAMPOO; Maximum daily exposure: 3 mg - US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 39 mg - US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION/ DROPS; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: SPONGE; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: SUSPENSION/ DROPS; Potency: ADJ PH - US: inactive ingredient database — Route: TOPICAL; Dosage form: SWAB; Potency: 0.01 %w/w - US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Potency: 0.85 mg - US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: GEL; Maximum daily exposure: 350 mg - US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: GEL, METERED; Maximum daily exposure: 350 mg - US: inactive ingredient database — Route: URETERAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: URETHRAL; Dosage form: SOLUTION; Potency: ADJ PH - US: inactive ingredient database — Route: VAGINAL; Dosage form: CREAM; Potency: 0.19 %w/w - US: inactive ingredient database — Route: VAGINAL; Dosage form: GEL; Maximum daily exposure: 20 mg - US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical. _Assessed by Greenveil._